Generic placeholder image

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery


ISSN (Print): 1872-2148
ISSN (Online): 2212-3334

Recent Efforts to Develop Imaging Methods and β -Cell-Specific Contrast Agents for Non-Invasive in vivo Assessment of β-Cell Mass

Author(s): Stephan Schneider, John Virostko, Astrid Reimann and Alvin C. Powers

Volume 3, Issue 3, 2009

Page: [157 - 161] Pages: 5

DOI: 10.2174/187221409789104737

Price: $65


Accurate, non-invasive assessment of the endogenous pancreatic β-cell mass in humans is currently not feasible. The development of a non-invasive assay of β-cell mass would be invaluable in the study of the natural course of diabetes and ongoing attempts to preserve or restore β-cell mass in patients with diabetes. This article reviews imaging methods and radiolabeled ligands which have been proposed or used for non-invasive assessment of the endogenous β- cell mass and discusses patents and future directions for the development of β-cell specific contrast agents.

Keywords: Non-invasive imaging, β-cell mass, imaging probes, BLI, MRI, PET

Next »

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy